Analytical Data
-
Gene name
WFDC2
- Application
-
Alternative Names
WFDC2; HE4; WAP5; EDDM4; Epididymal Protein 4; Epididymal Secretory Protein E4; Putative Protease Inhibitor WAP5; Major epididymis-specific protein E4
-
Species
Human
-
Source
E. coli
-
Tag
N- His & GST
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
Q14508
-
Expression Region
Ala30~Phe124
-
Molecular Weight
44kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
WFDC2, or WAP Four-Disulfide Core Domain 2, is a protein encoded by the WFDC2 gene, which is part of the whey acidic protein (WAP) gene family. This family is known for its role in various biological processes, including immune response, cell adhesion, and tissue remodeling. WFDC2 is predominantly expressed in epithelial tissues and has been implicated in several physiological and pathological conditions, such as cancer and inflammation. Research on recombinant WFDC2 protein has gained traction due to its potential in understanding disease mechanisms and its prospective applications in therapeutic development. The ability to produce this protein in recombinant form allows researchers to study its structure-function relationships, interaction with other proteins, and biological activities in a controlled environment. Given WFDC2's involvement in key processes like immunity and cell signaling, it represents a promising target for elucidating the molecular pathways involved in disease states and for exploring its potential as a biomarker or therapeutic agent in clinical settings.
